| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | Dec 2, 2022 | Akero Therapeutics, Inc. | Director | Sell | 17.5 | -23,131 | -7.52% | ✗ | $1.1M |
| Oct 28, 2022 | Nov 1, 2022 | Akero Therapeutics, Inc. | Director | Sell | 17.5 | -44,103 | -12.54% | ✗ | $1.8M |
| Oct 25, 2022 | Oct 27, 2022 | Akero Therapeutics, Inc. | Director | Sell | 15.0 | -285,487 | -44.81% | ✗ | $12.2M |
| Nov 24, 2020 | Nov 25, 2020 | Stoke Therapeutics, Inc. | Director | Buy | 90.0 | +375,000 | 2.23% | ✗ | $14.6M |
| Jul 10, 2020 | Jul 14, 2020 | Akero Therapeutics, Inc. | Director | Buy | 97.5 | +415,000 | 7.66% | ✗ | $14.9M |
| Jun 24, 2019 | Jun 25, 2019 | Akero Therapeutics, Inc. | Director | Buy | 100.0 | +900,000 | 19.93% | ✗ | $14.4M |
| Jun 21, 2019 | Jun 21, 2019 | Stoke Therapeutics, Inc. | Director | Buy | 97.5 | +1,388,889 | 9.02% | ✗ | $25M |
| Sep 22, 2014 | Sep 24, 2014 | Eledon Pharmaceuticals, Inc. | Director | Buy | 93.8 | +362,500 | 4.67% | ✗ | $5.4M |